Zacks Research Issues Positive Outlook for Docusign Earnings

Docusign Inc. (NASDAQ:DOCU) – Equities researchers at Zacks Research boosted their Q3 2026 earnings per share (EPS) estimates for Docusign in a research report issued to clients and investors on Thursday, September 25th. Zacks Research analyst Team now forecasts that the company will post earnings per share of $0.25 for the quarter, up from their previous forecast of $0.23. Zacks Research currently has a “Strong-Buy” rating on the stock. The consensus estimate for Docusign’s current full-year earnings is $1.17 per share. Zacks Research also issued estimates for Docusign’s Q1 2028 earnings at $0.40 EPS.

Other research analysts have also issued reports about the company. Morgan Stanley upped their target price on Docusign from $86.00 to $90.00 and gave the stock an “equal weight” rating in a research report on Monday, September 8th. Wells Fargo & Company boosted their target price on shares of Docusign from $80.00 to $85.00 and gave the stock an “equal weight” rating in a research report on Friday, September 5th. JMP Securities reaffirmed a “market outperform” rating and set a $124.00 target price on shares of Docusign in a research report on Friday, September 5th. Wall Street Zen upgraded Docusign from a “hold” rating to a “buy” rating in a research note on Saturday, September 13th. Finally, Robert W. Baird raised their target price on Docusign from $85.00 to $90.00 and gave the stock a “neutral” rating in a research report on Friday, September 5th. One investment analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and fourteen have assigned a Hold rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $94.14.

Docusign Stock Down 12.2%

DOCU stock opened at $72.09 on Monday. Docusign has a 12-month low of $60.60 and a 12-month high of $107.86. The company has a market cap of $14.50 billion, a price-to-earnings ratio of 54.20, a PEG ratio of 4.08 and a beta of 1.02. The company has a 50 day moving average of $76.87 and a two-hundred day moving average of $79.37.

Docusign (NASDAQ:DOCU) last announced its quarterly earnings data on Thursday, September 4th. The company reported $0.92 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.84 by $0.08. The firm had revenue of $800.64 million during the quarter, compared to the consensus estimate of $780.35 million. Docusign had a return on equity of 14.01% and a net margin of 9.08%.The business’s revenue for the quarter was up 8.8% on a year-over-year basis. During the same period in the prior year, the business earned $0.97 EPS. Docusign has set its Q3 2026 guidance at EPS. FY 2026 guidance at EPS.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of DOCU. State Street Corp increased its holdings in Docusign by 3.0% during the 2nd quarter. State Street Corp now owns 8,074,976 shares of the company’s stock valued at $628,960,000 after purchasing an additional 236,494 shares in the last quarter. American Century Companies Inc. increased its stake in shares of Docusign by 1.6% in the second quarter. American Century Companies Inc. now owns 5,564,318 shares of the company’s stock valued at $433,405,000 after buying an additional 86,560 shares in the last quarter. Geode Capital Management LLC raised its holdings in shares of Docusign by 1.5% in the second quarter. Geode Capital Management LLC now owns 3,985,808 shares of the company’s stock valued at $309,910,000 after buying an additional 59,941 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its position in Docusign by 18.6% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 2,028,505 shares of the company’s stock worth $165,120,000 after buying an additional 318,698 shares in the last quarter. Finally, Wellington Management Group LLP lifted its position in Docusign by 372.5% during the 1st quarter. Wellington Management Group LLP now owns 1,826,949 shares of the company’s stock worth $148,714,000 after buying an additional 1,440,269 shares in the last quarter. 77.64% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In related news, insider Robert Chatwani sold 13,817 shares of Docusign stock in a transaction dated Wednesday, September 17th. The shares were sold at an average price of $83.10, for a total transaction of $1,148,192.70. Following the completion of the transaction, the insider directly owned 71,162 shares of the company’s stock, valued at $5,913,562.20. This trade represents a 16.26% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director James A. Beer sold 450 shares of the business’s stock in a transaction dated Tuesday, September 16th. The shares were sold at an average price of $81.28, for a total transaction of $36,576.00. Following the completion of the transaction, the director owned 14,199 shares in the company, valued at approximately $1,154,094.72. This trade represents a 3.07% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 42,533 shares of company stock valued at $3,497,628. 1.66% of the stock is owned by company insiders.

Docusign announced that its board has authorized a stock repurchase plan on Thursday, June 5th that authorizes the company to repurchase $1.00 billion in shares. This repurchase authorization authorizes the company to reacquire up to 6.6% of its stock through open market purchases. Stock repurchase plans are generally a sign that the company’s management believes its stock is undervalued.

About Docusign

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.